...will not sponge up the operating challenges! We positively value Fresenius’ plans to change FMC’s legal structure and FMC’s ambition to provide more transparent reporting, as well as the higher cost-cutting ambitions. The basic issue of unknown future patient growth can not be solved. Additionally, it remains to be seen how ‘successful’ the change in FMC’s operating model will be and what the profitability line looks like. We hope the restructuring success can be easily tracked.
22 Feb 2023
Shareholders' new empowerment...
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Shareholders' new empowerment...
Fresenius Medical Care AG (FME:ETR) | 0 0 0.0%
- Published:
22 Feb 2023 -
Author:
Martin Schnee -
Pages:
5
...will not sponge up the operating challenges! We positively value Fresenius’ plans to change FMC’s legal structure and FMC’s ambition to provide more transparent reporting, as well as the higher cost-cutting ambitions. The basic issue of unknown future patient growth can not be solved. Additionally, it remains to be seen how ‘successful’ the change in FMC’s operating model will be and what the profitability line looks like. We hope the restructuring success can be easily tracked.